Selexis – global leader in mammalian cell line generation with unparalleled technology to translate scientific innovation into life-saving medicines.

Selexis is a pioneering life sciences company and a global leader in mammalian ...
See More (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology necessary to translate scientific innovation into life-saving medicines for patients. Selexis’ SUREtechnology Platform™ facilitates the rapid, stable, and cost-effective production of virtually any recombinant protein and provides seamless integration of the bioproduction continuum, spanning discovery to commercialization. With more than 95 partners worldwide, more than 75 biologic drug development programs and three commercial products utilizing its cell lines, Selexis has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research.